Impact of one High Dose of Ceftazidime Administrated before Minimally Invasive Multimodal Endoscopic Prostate Surgery

Authors

  • Virginia Coman Raluca Ripan Institute for Research in Chemistry, Babeș-Bolyai University, 30 Fântânele Street, 400294, Cluj-Napoca, Romania
  • Mihaela Vlassa Raluca Ripan Institute for Research in Chemistry, Babeș-Bolyai University, 30 Fântânele Street, 400294, Cluj-Napoca, Romania
  • Miuța Filip Raluca Ripan Institute for Research in Chemistry, Babeș-Bolyai University, 30 Fântânele Street, 400294, Cluj-Napoca, Romania
  • Simion Beldean-Galea Faculty of Environmental Science & Engineering, Babeș-Bolyai University, 30 Fântânele Street, 400294, Cluj-Napoca, Romania
  • Tiberius Dicu Faculty of Environmental Science & Engineering, Babeș-Bolyai University, 30 Fântânele Street, 400294, Cluj-Napoca, Romania
  • Radu-Tudor Coman Faculty of Medicine, Iuliu Hațieganu University Medicine & Pharmacy, 8 Babeș Street, 400012, Cluj-Napoca, Romania

DOI:

https://doi.org/10.33892/aph.2021.91.195-197

Keywords:

Ceftazidime, HPLC-DAD, minimally invasive multimodal endoscopic prostate surgery, blood, tissue

Published

2021-11-15

How to Cite

(1)
Coman, V.; Vlassa, M.; Filip, M.; Beldean-Galea, S.; Dicu, T.; Coman, R.-T. Impact of One High Dose of Ceftazidime Administrated before Minimally Invasive Multimodal Endoscopic Prostate Surgery. Acta Pharm Hung 2021, 91, 195-197.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License